Efficacy and Safety of Norketotifen in Uncomplicated Influenza-like Illness

Summary

This is a Phase 2b, multi-center, double-blind, randomized, placebo-controlled, parallel-group study of NKT versus placebo in otherwise healthy adults presenting with acute uncomplicated ILI due to influenza or other respiratory viruses in a community setting.

Timeline

Start

2020-12-14

Primary completion

2022-01-25

Completion

2022-02-09

Drugs

Indications